NCT00096759

Brief Summary

The purpose of this study is to compare the effectiveness of relaxation therapy and tai chi in treating the symptoms of rheumatoid arthritis (RA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Nov 2004

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2004

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

November 15, 2004

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 16, 2004

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2007

Completed
Last Updated

March 22, 2013

Status Verified

March 1, 2013

Enrollment Period

2.7 years

First QC Date

November 15, 2004

Last Update Submit

March 21, 2013

Conditions

Keywords

ArthritisTai ChiMeditationRelaxation Techniques

Outcome Measures

Primary Outcomes (2)

  • RA-related disability

  • Health functioning

Interventions

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Active adult onset rheumatoid arthritis
  • Stable on disease-modifying antirheumatic drugs (DMARDs) or biologic medications
  • Able to walk without use of an assistive device
  • Resides in greater Los Angeles area
  • Willing and able to comply with study requirements

You may not qualify if:

  • Uncontrolled or untreated medical conditions
  • Frequent or uncontrolled disease flares
  • Use of certain medications any medical condition deemed by the investigators to interfere with either the patient's safe participation or interpretation of the study data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States

Location

University of California, Los Angeles Medical Center

Los Angeles, California, 90095, United States

Location

MeSH Terms

Conditions

Arthritis, RheumatoidArthritis

Interventions

Relaxation Therapy

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Jennifer Pike, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2004

First Posted

November 16, 2004

Study Start

November 1, 2004

Primary Completion

August 1, 2007

Study Completion

August 1, 2007

Last Updated

March 22, 2013

Record last verified: 2013-03

Locations